The global treatment-resistant hypertension management industry growth is projected to grow at a CAGR of 14% between 2023 and 2033, from US$ 43 million in 2023 to US$ 159.41 million by 2033. The market for controlling hypertension that is resistant to therapy grew at a CAGR of 11% from 2018 to 2022. The global treatment-resistant …